During Tuesday’s Current trade, Shares of WisdomTree Investments, Inc. (NASDAQ:WETF), gain 1.41% to $19.40.
WisdomTree Investments, Inc. (WETF), an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager recently stated net income of $24.2 million for the second quarter of 2015 or $0.18 per share on a fully diluted basis. This compares to $10.6 million in the second quarter of 2014 and $12.1 million in the first quarter of 2015.
Recent Business Developments
Personnel
- On June 15, 2015, the Company named Kurt MacAlpine Executive Vice President and Head of Global Distribution
- On July 1, 2015, the Company declared plans for a Japan office and the appointment of Jesper Koll as Chief Executive Officer of WisdomTree Japan K.K.
- On July 23, 2015, the Company declared the expansion of its Japan Administration team with the appointment of Junichi Kamitsubo as Head of Sales and Atsushi Yamamoto as Chief Compliance Officer of WisdomTree Japan K.K.
WisdomTree Investments, Inc., through its auxiliaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes.
Shares of Vital Therapies Inc (NASDAQ:VTL), inclined 11.99% to $4.08, during its current trading session.
Vital Therapies, Inc. (VTL) declared negative top-line data from the phase III VTI-208 study evaluating the ELAD System in patients with alcohol-induced liver decompensation. The stock nosedived 75.1% in after-market trading.
The randomized, controlled, open-label VTI-208 study enrolled 203 patients. While 96 were randomized to the treated group, 107 were randomized to the control group. The study failed to meet the primary endpoint of overall survival through at least 91 days assessed using the Kaplan Meier statistical method. No noteworthy difference in hazard ratio between the treated and control arm of the study was observed.
Vital Therapies, Inc., a biotherapeutic company, focuses on developing a cell-based therapy for the treatment of acute liver failure in the United States. Its ELAD system is an extracorporeal bio-artificial liver therapy that is in Phase III clinical trials to allow the patients own liver to regenerate to a healthy state, or to stabilize the patient until transplant. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is headquartered in San Diego, California.
Toll Brothers Inc (NYSE:TOL), during its Tuesday’s current trading session decreased -0.71% to $37.80.
Toll Brothers, Inc. (TOL) the nation’s leading builder of luxury homes, recently declared results for its third quarter and nine months ended July 31, 2015.
FY 2015 Third Quarter Financial Highlights:
- FY 2015’s third-quarter net income was $66.7 million, or $0.36 per share diluted, contrast to net income of $97.7 million, or $0.53 per share diluted, in FY 2014’s third quarter.
- Pre-tax income was $107.5 million, contrast to pre-tax income of $151.3 million in FY 2014’s third quarter. Comprised of in FY 2015’s third-quarter cost of sales were impairments of $18.0 million and a $4.9 million net enhance in reserves, contrast to impairments of $6.0 million and a reserve reversal of $7.0 million in FY 2014’s third quarter.
- Revenues of $1.03 billion and home building deliveries of 1,419 units declined 3% in dollars and 2% in units, contrast to FY 2014’s third quarter. The average price of homes delivered was $724,000, contrast to $732,000 in FY 2014’s third quarter.
- Net signed contracts of $1.23 billion and 1,479 units rose 30% in dollars and 12% in units, contrast to FY 2014’s third quarter. The average price of net signed contracts was $834,000, the highest quarterly average in the Company’s history, contrast to $717,000 in FY 2014’s third quarter, driven by an enhance in the number and average price of California contracts.
- For the first four weeks of August, the start of the Company’s FY 2015 fourth quarter, net contracts were up 16% in units contrast to the same period in FY 2014.
Toll Brothers, Inc., together with its auxiliaries, designs, builds, markets, and arranges finance for detached and attached homes in luxury residential communities in the Unites States. It is also involved in building and selling homes in urban infill markets. In addition, the company owns, develops, and operates golf courses and country clubs that are associated with various planned communities; and acquires and develops commercial and apartment properties.
Finally, H & R Block Inc (NYSE:HRB), gained 2.97%, to $32.98.
H&R Block, Inc. (HRB), the world’s largest consumer tax services provider, recently declared that H&R Block, H&R Block Bank and BofI have received regulatory approvals from the Office of the Comptroller of the Currency (OCC) and the Board of Governors of the Federal Reserve System (Federal Reserve) to proceed with the purchase and assumption agreement formerly declared on April 10, 2014. Under the agreement, H&R Block Bank has agreed to sell certain assets and transfer certain liabilities, counting all of its deposit liabilities, to BofI.
H&R Block anticipates the ongoing annual net financial impact to be dilutive by about $0.08 to $0.10 per share starting in fiscal year 2016. The company also anticipates to incur one-time charges for transaction and related costs of about $0.02 to $0.03 per share in fiscal year 2016. All per share amounts are based on current fully diluted shares outstanding.
H&R Block, Inc., through its auxiliaries, provides tax preparation, banking, and other services to the general public primarily in the United States, Canada, and Australia. The company offers assisted income tax return preparation and related services through a system of retail offices operated directly by the company or by franchisees; and online tax services, such as tax advice, professional and do-it-yourself (DIY) tax return preparation, and electronic filing services through its Website hrblock.com.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
